The role of some key factors in predicting PCNSL prognosis is unclear, such as the proto-oncogene serine/threonine (Ser/Thr) protein kinase 1 (PIM1), a known target for somatic hypermutation mechanisms in PCNSL [150, 320, 383]. The gene discussed is PIM1; the disease is primary central nervous system lymphoma.